Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
re: RBTE
sounds like it was worth their while:
https://www.socketmobile.com/about-us/media-center/blog/socket-talk/2016/03/22/retail-business-technology-expo-olympia-london-9-10th-march-2016
Thats what it sounds like to me. They are trying to cut everywhere they can at this point. The Q wasnt too bad, less rev but loss was very small....close to break-even. If reporting costs are 10% of 400k revenue, then yearly expenses must be @ 150k-160k to stay on the OTCQB. Until they get back on terra firma, maybe it does make sense to trade on the pinks and use that savings on other things, like payroll or marketing. As an investor, im not a fan of lack of transparency. As far as signing up new customers, maybe less transparency is better for business. I wish B Scada would sign a large contract or two before this becomes necessary. Its been frustrating holding this stock as long as i have, from 20 to 70 to under 20 cents. That loss of oil revenue killed our momentum. So much promise here but we keep hitting snags.
Someone back today, bidding for 200k shares at .02. Hopefully AMPG can stay above .02 from here on...
edit: disappeared as soon as I posted this. Lol...
looks like a good space to be in:
http://finance.yahoo.com/news/marijuana-economy-will-hit-44-billion-impact-by-2020-133004729.html
SSKILLZ1, please note:
LLTP changed its symbol to OPNT
Thanks
I agree. Partnerships and improvement in the product offerings are great, but signing deals to move revenue forward is key at this point.
B-Scada Releases Status Device Cloud for Microsoft Azure
http://scada.com/News/201602251/bscada-releases-status-device-cloud-for-microsoft-azure
Im pretty sure any legit offer would have to follow proper SEC protocol, and thus a filing with the SEC would be required for such an offer.
Required disclosures
In the United States, under the Williams Act, codified in Section 13(d) and Section 14(d)(1) of the Securities Exchange Act of 1934, a bidder must file schedule TO with the SEC upon commencement of the tender offer. Among the matters required to be disclosed in schedule TO are: (i) a term sheet which summarizes the material terms of the tender offer in plain English; (ii) the bidder's identity and background; and (iii) the bidder's history with the target company. In addition, a potential acquirer must file Schedule 13D within 10 days of acquiring more than 5% of the shares of another company.
Sounds very positive (with the exception of "some inertia" in Q1 due to moving costs)
A New Era Begins for State-of-the-Art Low Noise (LNA) and Power Amplifier (PA) Technology
February 16, 2016 12:39 PM EST
BOHEMIA, NY -- (Marketwired) -- 02/16/16 -- AmpliTech Group, Inc. (OTCQB: AMPG) announced today that they have completed the move to their new facility at 620 Johnson Avenue in Bohemia, NY. CEO Fawad Maqbool stated, "The new facility is located in the heart of the Industrial Center in Bohemia, NY. It is located minutes from the Islip MacArthur Airport, a main business hub for Long Island and Southwest Airlines. This new location and double the space from our previous location will allow us to increase our productivity and exposure to the larger OEM customers that we will now be targeting for expanding our business. This strategic move is part of our plan to grow our sales, revenue, and profitability as we have been doing throughout the last 15 months. In the coming months we will finalize the development of our revolutionary CoolAmp" Series of Low Noise Amplifiers (LNA) for wireless and satellite markets and introduce a new line of SSPA (Small Signal Power Amplifiers) and HPA and MPA (High Power and Medium Power Amplifiers) for the same markets.
These products will greatly improve the mobile and wireless network signals and push us into the next generation of wireless productivity. The expanded product lines will launch us into these lucrative and rapidly growing large volume markets. We received some large orders last quarter and we plan to continue to book large orders for the coming months and expect to increase our revenue considerably for the rest of the year. Our first quarter will exhibit some inertia due to the move and logistic issues, but by the second quarter, we will be well on our way."
B-Scada Enters Industrial IoT and Smart City Cloud Partnership with Libelium
Wednesday, February 10, 2016
CRYSTAL RIVER, FL: B-Scada, Inc. (OTCQB: SCDA) has announced a new partnership with Libelium, an award-winning manufacturer of wireless sensing technology optimized for Industrial IoT and Smart City applications. B-Scada will provide Libelium customers with a powerful and sophisticated Cloud software option to visualize their real-time sensor data. B-Scada has also included the Libelium data provider in its popular software platforms for current and future customers who may be interested in implementing Libelium sensing technology.
Libelium's new Cloud partners include software providers from Asia, North America, and Spain, reaching markets worldwide. Based on the Meshlium wireless gateway, Libelium's Cloud connector framework allows easy configuration of Cloud platforms without the need of programming or further integration to reduce time-to-market for IoT and Industrial IoT (IIoT) applications.
About Libelium
Libelium delivers a powerful, modular, easy to program open source sensor platform for the Internet of Things, enabling system integrators to implement reliable Smart Cities and M2M solutions with minimum time to market. Their versatile platform allows implementation of any Wireless Sensor Network, from Smart Parking to Smart Irrigation solutions. Learn more at www.libelium.com.
Bullish forecast for the healthcare handheld market. Socket included among the key players.
http://www.medgadget.com/2016/02/handhelds-in-healthcare-market-propelled-by-emerging-smart-technologies.html
http://www.industrytoday.co.uk/market-research-industry-today/global-handhelds-in-healthcare-market-analysis-trends-and-forecast-up-to-2023/47301
Is this what you are referring to?
“Some of the productivity savings will be invested in important initiatives such as brand building, harm reduction and regulatory capabilities,” said Marty Barrington, Altria’s chairman, president and chief executive officer, in a conference call with industry analysts and media representatives.
“Continually challenging our cost structure and investing in the future remain important for us as we focus on delivering strong results for the long term,” he said.
http://www.richmond.com/business/local/article_d209a3b7-acfb-5146-9029-b10174d21654.html
I havent read when the earnings CC will be held. Anyone know?
and
22nd Century’s Very Low Nicotine Cigarettes Identified as an Important Public Health Tool to Reduce Smoking Rates in New Ze...
Today : Wednesday 3 February 2016
Click Here for more 22nd Century Group, Inc. Charts.
81% of surveyed smokers believe nicotine content of cigarettes should be reduced to very low levels so that they are less addictive
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that public health advocates in New Zealand have contacted 22nd Century to advance their plans to introduce 22nd Century’s Very Low Nicotine (VLN) cigarettes into commerce in New Zealand at a tax rate substantially lower than that of conventional cigarettes. Taking note that the Company recently launched MAGIC 0 Very Low Nicotine cigarettes in Europe, and that 22nd Century submitted to the U.S. Food and Drug Administration (FDA) in December 2015 a Modified Risk Tobacco Product application for BRAND A VLN cigarettes, New Zealand public health advocates believe a Very Low Nicotine cigarette that is taxed at lower rates could be an important part of the public health initiative in New Zealand that aims to achieve a smoke free New Zealand by the year 2025.
Conditions in New Zealand are favorable for such a national policy on smoking reduction. On January 8, 2016, the New Zealand Health Promotion Agency reported that a population-based survey of approximately 2,600 adults in New Zealand showed wide support (81% of those surveyed, 63% of smokers) for the concept that "nicotine content of cigarettes should be reduced to very low levels so that they are less addictive."
One of New Zealand’s most experienced researchers on smoking policy and cigarettes, Dr. Murray Laugesen, has been advocating for a national nicotine policy for several years. In 2012, Dr. Laugesen wrote in The New Zealand Medical Journal: “Very low nicotine… cigarettes (not currently on sale in New Zealand) have become commercially available [elsewhere]… and we propose that these [22nd Century Group] cigarettes, which actually assist smokers to quit and which can reduce tobacco addiction, merit a lower rate of excise [tax] to make them available at a lower price than other (addictive) cigarettes.” New Zealand Medical Journal 14th December 2012, Volume 125 Number 1367. In the same article, Dr. Laugesen also cited the many independent, scientific clinical trials that have shown that the use of 22nd Century’s proprietary Very Low Nicotine tobacco cigarettes results in reduced cigarette consumption, reduced nicotine exposure, and increased rates of smoking cessation.
To date, there have been seven independent clinical studies using 22nd Century’s proprietary Very Low Nicotine tobacco cigarettes. The following two clinical studies were conducted in New Zealand, the third clinical study was recently published in The New England Journal of Medicine:
2009 randomized trial by Dr. Natalie Walker, et al. conducted in New Zealand among smokers seeking to quit and utilizing 22nd Century’s Very Low Nicotine cigarettes concluded that a reduction in the level of nicotine in cigarette tobacco can reduce the level of nicotine dependence in smokers and do so without adverse effects on cardiovascular biomarkers or significant compensatory smoking.
2014 randomized trial by Dr. Natalie Walker, et al. conducted in New Zealand found that among smokers unmotivated to quit, and in contrast to smokers of conventional cigarettes, smokers of 22nd Century’s Very Low Nicotine cigarettes reduced cigarette consumption, reduced nicotine exposure, and increased quitting.
2015 double-blind, parallel, randomized clinical trial by Dr. Eric Donny, et al. published in the October 2015 issue of The New England Journal of Medicine found that smokers of 22nd Century’s Very Low Nicotine cigarettes reduced their nicotine exposure, nicotine dependency, and cigarettes smoked per day. These same smokers reported little evidence of negative effects (including compensatory smoking). Smokers of 22nd Century’s Very Low Nicotine cigarettes were also twice as likely to attempt quitting.
“Reducing the nicotine in cigarettes to non-addictive levels is a promising regulatory strategy to drastically reduce the harm caused by smoking,” explained Henry Sicignano, III, President and Chief Executive Officer at 22nd Century Group. “We believe that 22nd Century’s proprietary Very Low Nicotine cigarettes will be an invaluable public health tool; we stand ready to assist New Zealand in its progressive and pragmatic approach to a national nicotine reduction policy.”
22nd Century Group Announces $5.5 Million Registered Direct
Today : Wednesday 3 February 2016
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has entered into an agreement with one existing institutional investor to receive $5.5 million in gross proceeds in a registered direct offering through the sale of common stock and warrants consisting of 5,000,000 shares of its common stock and 66-month warrants to purchase 2,500,000 shares of common stock at an exercise price of $1.21 per share (not exercisable for six months from issuance). If the warrants are exercised for cash in full, the Company would receive additional gross proceeds of approximately $3.0 million.
The offering is expected to close on or about February 5, 2016, subject to customary closing conditions, including approval of a NYSE MKT listing application. The net proceeds of the financing will be used for general corporate purposes, including working capital.
Chardan Capital Markets, LLC acted as the sole placement agent for this transaction.
"one serving of eggplant you get the same amount of nicotine as smoking 1 cigarette"
Your calculations are slightly off, according to this: http://www.huffingtonpost.com/2012/06/15/nicotine-in-vegetables_n_1597087.html
Annual report, a good read:
http://scada.com/Content/AnnualReports/2015AnnualReport.pdf
22nd Century Launches New RED SUN® Extremely Nicotine Website
22nd Century Group, Inc. (AMEX:XXII)
RED SUN smokers are unapologetic about smoking and deserve the best tobacco has to offer.
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company focused on tobacco, announced today that the Company has launched a remastered RED SUN website that powerfully communicates the brand’s new Extremely Nicotine message. Underpinning the www.redsuncigarettes.com website – and the brand itself – is RED SUN’s mission: “To give smokers the BOLDEST, most UNAPOLOGETIC and HIGHEST NICOTINE cigarette in America!”
“The RED SUN website serves as our Company’s “Ground Zero” of brand awareness,” explained Nathan P. Schmitt, Director of Marketing for 22nd Century. “Positioned very much like Red Bull® energy drinks, RED SUN is a bold, super-premium brand. Consumers have embraced RED SUN; in fact, as showcased on our website, nearly 200 adult smokers across the country have become ‘RED SUN extremists’ by tattooing our brand’s logo on their bodies!”
Though 22nd Century does not encourage non-smokers to start smoking, or current smokers to smoke more, the Company believes strongly that consumers should have a choice of nicotine levels between cigarette brands. The new RED SUN website articulates the brand’s core values including: Authenticity, Independence, Boldness, and an Unconventional attitude. Explaining why “More is Better” and the reason behind the brand’s audacious high nicotine messaging, the RED SUN website declares: “We own the formula for America’s highest nicotine tobacco! No other brand can match RED SUN’s EXTREME nicotine! Why is more nicotine better? RED SUN smokers can enjoy greater satisfaction with every cigarette. Our smokers are unapologetic about smoking and deserve the best tobacco has to offer.”
22nd Century’s factory manager, Barry Saintsing is highlighted on the RED SUN website as the “father of the blend.” Identified as RED SUN’s Master Tobacconist, Saintsing served 36-years with RJ Reynolds as a Master Product Developer where he worked to perfect tobacco blends in the United States and in dozens of other countries around the world. “The RED SUN blend is carefully balanced to provide smokers with a powerful, undiluted tobacco taste,” explained Mr. Saintsing. “My work with RED SUN is especially fulfilling since so many smokers have told me how much they really like the bold, premium taste that RED SUN delivers.”
A new initiative for the Company is introduced on the website’s “Plant a Tree” page. 22nd Century is working with four non-profit organizations (Green Seattle Partnership, The Park People, California ReLeaf, and Friends of Trees) to plant a tree for every case of RED SUN cigarettes that is sold. The stated goal of the Company’s new Green Thumb initiative is to promote urban and community forest renewal and to improve the natural beauty of urban centers and parks across America.
The RED SUN website address is www.redsuncigarettes.com. It is open to adults of legal smoking age.
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company. Visit www.xxiicentury.com for more information.
22nd Century Delivers 4.95 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse
Today : Tuesday 26 January 2016
Phase III study already underway examines different uses of 22nd Century’s SPECTRUM® Very Low Nicotine cigarettes to break smokers’ addiction to nicotine
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company shipped 4.95 million SPECTRUM® research cigarettes for the National Institute on Drug Abuse (NIDA), a department of the National Institutes of Health (NIH).
As the only company in the world capable of producing Very Low Nicotine (VLN) tobacco products, 22nd Century was chosen by NIDA to supply its proprietary cigarettes as a subcontractor under a federal government contract. The main SPECTRUM® product line consists of a series of cigarette styles that have a fixed “tar” yield but varying nicotine yields over a 50-fold range – from very low to high. Altogether, SPECTRUM® features 24 styles, 11 regular and 13 menthol versions, with 8 different levels of nicotine content. SPECTRUM® is strictly for research purposes and is not sold as a commercial cigarette.
The available scientific literature, gained in part through independent clinical trials utilizing SPECTRUM® research cigarettes, shows that smoking 22nd Century’s VLN cigarettes results in reduced nicotine exposure with minimal compensatory smoking behavior and no greater exposure to harmful or potentially harmful toxicants.
New clinical trials using 22nd Century’s SPECTRUM® cigarettes are already underway. Most notably, a Phase III study featuring 1,250 participants and sponsored by the University of Pittsburgh, in collaboration with the National Institute on Drug Abuse (NIDA) is comparing two different approaches to help smokers lose their addiction to nicotine: an immediate reduction in nicotine content in cigarettes to non-addictive levels versus a gradual reduction in nicotine content in cigarettes to non-addictive levels.
“22nd Century has now delivered over 22 million SPECTRUM® research cigarettes for the National Institute on Drug Abuse,” explained Henry Sicignano, III, President and Chief Executive Officer of 22nd Century Group. “We are proud to be a part of such important public health research efforts and we are pleased that there is growing support for a national nicotine policy that will give consumers a Very Low Nicotine cigarette choice.”
Without SPECTRUM® cigarettes, many important research projects investigating the exposure and behavioral effects of different nicotine levels in cigarettes would simply be impossible to conduct. Most recently, SPECTRUM® cigarettes were an integral part of the study conducted by Eric C. Donny, Ph.D., et al and the Center for the Evaluation of Nicotine in Cigarettes and published in The New England Journal of Medicine (N Engl J Med 2015; 373:1340-1349). In this study, researchers determined that SPECTRUM®’s Very Low Nicotine style cigarettes were found to reduce exposure to, and dependence on, nicotine and to reduce cravings while adverse events were generally mild and similar among groups. Moreover, in the 30 days following the trial, smokers of SPECTRUM®’s very low nicotine style cigarettes reported they attempted to quit smoking at a rate double that of participants who smoked standard nicotine style cigarettes (34.7% vs. 17%).
22nd Century cited the Donny trial, in addition to extensive data gathered from several other independent clinical trials, in the Company’s recently submitted Modified Risk Tobacco Product (MRTP) application to the U.S. Food and Drug Administration (FDA). 22nd Century’s MRTP application seeks a reduced exposure order so that 22nd Century’s “BRAND A” Very Low Nicotine cigarettes may be introduced into commerce in the United States. The Company’s application to the FDA requests that BRAND A packaging and marketing be allowed to disclose to consumers that the Company’s proprietary Very Low Nicotine cigarettes reduce smokers’ exposure to nicotine.
At present, the United States is completely devoid of any “reduced exposure cigarette” option. If 22nd Century’s application to the FDA is successful, the Company’s Very Low Nicotine cigarettes will offer millions of American smokers the first reduced exposure cigarette choice.
About 22nd Century Group, Inc.
22nd Century Group is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company. Visit www.xxiicentury.com for more information
from the 8-K out this morning:
Item 8.01 Other Events.
On January 25, 2016, warrants issued on January 25, 2011 granting the holders the right to purchase a total of 6,831,115 shares of common stock of 22nd Century Group, Inc. (the “Company”) expired. As a result, the total number of outstanding warrants to purchase the Company’s common shares decreased by approximately 41%, from 16,567,736 to 9,736,621. As of January 25, 2016, there were 71,006,844 shares of the Company’s common stock outstanding.
22nd Century’s Central American Growing Program to Yield Large Quantities of Proprietary Seed Stock to Support Very Low Nic...
Date : 01/21/2016 @ 9:50AM
Source : Business Wire
Stock : 22ND Century Grp., Inc. (XXII)
Quote : 1.25 0.07 (5.93%) @ 9:41AM
Initiative will produce seed sufficient to grow tens of thousands of acres of Very Low Nicotine tobacco
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that its Central American growing program is a great success. Now nearing harvest, the specially-propagated Central American tobacco crop is expected to produce sufficient quantities of Very Low Nicotine tobacco seed stock to support 22nd Century’s increasing distribution of Very Low Nicotine (“VLN”) tobacco cigarettes in Europe, as well as the anticipated future distribution of VLN tobacco cigarettes in the United States, and the potential sales of VLN tobacco leaf in Asia.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160121005829/en/
Central American field shown with juvenile 22nd Century Very Low Nicotine tobacco plants (Photo: Bus ...
Central American field shown with juvenile 22nd Century Very Low Nicotine tobacco plants (Photo: Business Wire)
As reported in October 2015, the United States Department of Agriculture (USDA) issued a phytosanitary certificate to 22nd Century to facilitate export of the Company’s proprietary Nicotiana tabacum (tobacco) seeds to select growers in Central America. As a result of the Company’s successful field trials, the proprietary Very Low Nicotine tobacco seed in production will allow 22nd Century to greatly expand its tobacco leaf growing programs in both the United States and in Central America. The tobacco plants in Central America are expected to produce seed sufficient to grow tens of thousands of acres of Very Low Nicotine tobacco.
“The positive results of our Central American tobacco seed production program could not have come at a better time,” explained Henry Sicignano, III, President and Chief Executive Officer of 22nd Century Group. “Now 22nd Century will have sufficient stockpiles of VLN seeds to support increased distribution of the Company’s MAGIC “O” cigarettes as well as launches of our other proprietary Very Low Nicotine products around the world.”
Seems like a pretty big difference in how Silk lowered nicotine (fillers and air filters) and how XXII's plant breeding lowers it in the actual tobacco plant.
"It is a misconception that the tobacco in Silk Cuts contains less nicotine than other cigarette tobacco. The lower nicotine levels are caused by the design of the filter, which has many more holes than regular strength cigarette filters, to mix the smoke with air."
News
22nd Century Meets with FDA on Historic Modified Risk Tobacco Product Application for World’s Lowest Nicotine Tobacco Cigarette
Date : 01/19/2016 @ 10:27AM
“The most promising regulatory policy option for preventing 20 million premature deaths”
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that last week the Company met with administrators and assigned scientific reviewers at the U.S. Food and Drug Administration (FDA) to review the Company’s Modified Risk Tobacco Product (MRTP) application for BRAND A Very Low Nicotine (VLN) cigarettes.
The FDA contacted 22nd Century immediately upon receiving the Company’s MRTP application and facilitated – less than 14 days after the Company’s submission – a meeting at FDA headquarters to discuss the application and the review process. In attendance were nine members of 22nd Century’s team, including executive management, consultants and attorneys, along with 22 FDA staff members; more than 20 additional FDA staff members attended telephonically.
Conclusive independent laboratory testing proves that 22nd Century’s BRAND A cigarettes contain less than 0.6 mg nicotine per cigarette and less than 0.05 mg nicotine yield per cigarette. In each case, this represents a reduction of at least 95% less nicotine relative to “Big Tobacco” cigarette brands, including Marlboro®, Camel®, Newport®, and Natural American Spirit®. The Company’s Modified Risk Tobacco Product application to the FDA requests that BRAND A packaging and marketing be allowed to disclose to consumers that the product contains 95% less nicotine than conventional brands and drastically reduces smokers’ exposure to nicotine.
“I am very pleased with the FDA’s prompt attention to our MRTP application,” stated Henry Sicignano, III, President and Chief Executive Officer of 22nd Century Group. “For U.S. smokers who wish to reduce their exposure to nicotine, 22nd Century’s Very Low Nicotine cigarettes are an incredibly important product. Consumers deserve a Very Low Nicotine product choice.”
Under the 2009 Tobacco Control Act, the FDA cannot ban conventional tobacco products, such as cigarettes and smokeless tobacco, or require the total elimination of nicotine in tobacco products. However, the FDA has the authority to order the reduction of nicotine to non-addictive levels in some or all cigarettes sold in the United States.
Mr. Sicignano explained, “Besides paving the way for the world’s first reduced exposure cigarette, 22nd Century’s proprietary technology gives the FDA an invaluable tool if the FDA desires to require all U.S. cigarette brands to offer consumers a Very Low Nicotine brand style at non-addictive levels… a very exciting prospect for public health, to say the least.”
With more than 200 patents relating to the genes in the tobacco plant responsible for nicotine production, 22nd Century is the only company in the world capable of producing virtually nicotine-free tobacco. The finished cigarettes containing 22nd Century’s proprietary Very Low Nicotine tobacco have the taste and sensory characteristics of conventional cigarettes, but contain only trace amounts of nicotine. The Company looks forward to continuing to work closely with the FDA in the MRTP application process in order to secure a marketing order that will facilitate reduced exposure labelling for BRAND A Very Low Nicotine cigarettes.
In the October 1, 2015 edition of The New England Journal of Medicine, Drs. Michael Fiore and Timothy Baker (see Fiore) wrote: “Reducing the nicotine content of combustible tobacco to levels that will not sustain dependence seems to us to be the most promising regulatory policy option for preventing [at least] 20 million premature deaths.” 22nd Century believes that, beginning with the Company’s BRAND A Modified Risk Tobacco Product application, the FDA has the option to begin a process of reducing the nicotine content of U.S. cigarettes. In the words of former FDA Commissioner Dr. David Kessler, reducing the nicotine levels in cigarettes to non-addictive levels is “the ultimate harm reduction strategy.”
8-K out.
http://ih.advfn.com/p.php?pid=nmona&article=69991204&symbol=SCDA
Looks like 3.35M shares sold to Yorkmont at .20/share, so $670,000 to B-Scada to fund their new sensor biz. While I'm not a fan of dilution, reality is the company needs cash in order to fund the expansion and this has been discussed as a necessary step. Could be worse, as the stock has been trading at 20 cents anyway (no discount) and 3.35M extra shares isnt overly dilutive in the grand scheme of things (@ 30M outstanding).
CEO from Uptake was on CNBC this morning. He previously founded a company called Groupon (ever heard of it?). Anyway, sounds like his new company (founded in 2014) is after the same IoT platform niche B-Scada is after. I bet his company is well-funded so this new equity investment is essential to get B-Scada up and moving and not left in the dust as this market takes off.
Any thought?
Down @ 35% in 2016? Unreal.
BMAK only has 10K shares to sell. Seems odd that the CEO would be buying 700K+ shares in the open market and putting 10K up for sale at the same price. Who knows but the news flows seems very bullish for 2016.
Kudos to management for meeting their deadline.
I'd love for the major media outlets to start picking the story up, so the application gets public support. Wonder if XXII management has contacted the AP, NY Times, etc to try to get the word out.
The tepid stock reaction today is probably a result of the general market conditions as well as this news already being anticipated/expected. I agree, though, this is huge news with far reaching implications on the tobacco and health areas of our country.
While the 2015 S&P performance was essentially flat, as a group, biotech notched a 5% gain and tobacco an impressive 17% gain. Regardless of politics, economic uncertainty, etc, these industries continue to be in-favor.
Re: FDA submission. Swedish Match seemed to get some good press from the media with their snus submission. As our submission seems to have wider implications, I hope XXII management has a plan to send out a statement to media channels so we get some widespread free press upon submission. Go XXII
I think "January 2015" was a typo. If you read the shareholder letter, Henry states that a group of scientists and business people from Asia will be visiting the NC plant in January 2016. Everything else in Atlanta's post seems current.
Interesting stuff. Thanks for posting.
Over 1M in volume today. Probably some last minute tax loss selling and buyers taking the opportunity to scoop up a large quantity of cheap shares. Hopefully 2016 is Amplitech's year!
Yeah, its been a disappointing year for revenue and stock performance. I figured we'd be making more progress w/ Status deployments by now, and didnt count on losing that steady revenue generated from the energy sector (no one expected oil prices to collapse as they have, so not B-Scada's fault). That said, Ron and company are innovating and staying the course they set out. We will climb out of the hole in due time, imo. With the added sensor component, they will now have a complete offering for potential customers in a rapidly growing (global) market. I'm underwater on my investment here but have confidence that I will do just fine w/ continued patience.
The Q filing should shed a little more light on what we can expect going forward...
B-Scada Group Releases Preliminary Unaudited 2015 Financials and Guidance
Monday, December 28, 2015
CRYSTAL RIVER, FL: B-Scada, Inc. (OTCQB: SCDA) has released their preliminary unaudited financials for 2014-2015. B-Scada, Inc. (B-Scada Group) includes B-Scada, Inc., B-Scada Soluciones Industriales SL. and Monitor Sensing Technologies Inc. B-Scada provides software and hardware solutions for the monitoring and analysis of real time data in the SCADA (Supervisory Control and Data Acquisition), IoT (Internet of Things) and Smart City domains. B-Scada systems are sold worldwide in various verticals including building automation, transportation, smart grid, manufacturing, agriculture and commerce. B-Scada solutions are deployed onsite and as cloud hosted solutions in a SAAS (Software as a Service) model.
Overview
It has been a very productive year for the company. B-Scada has opened its European subsidiary in Cartagena, Spain providing us with European presence and the opportunity to engage with our customers in Spanish and Portuguese. Technology from our Status Enterprise SCADA and HMI systems has been utilized to launch our VoT (Virtualization of Things) IoT platform for monitoring and archiving real time data from various locations and hardware types through the Internet. A new B-Scada initiative, Monitor Sensing Technologies Inc. is a wholly owned subsidiary of B-Scada Inc. will be launching a line of lightweight sensors designed for residential and light commercial use in early 2016. Monitor Sensing will be utilizing Microsoft Azure and B-Scada software technology in the cloud for remote monitoring and archiving IoT data. Our SCADA software solutions have been enhanced to provide CMMS (Computerized Maintenance Monitoring System) capabilities. CMMS, when used in conjunction with our workflow and notifications capabilities now provides a true predictive maintenance system integrated with the monitoring of real time data.
2016 Strategy
B-Scada's strategy will be changing as we move into 2016. Our growth plans continue to stay focused on software revenues providing high margins and growth opportunity for the business, but we have also recognized that our SCADA, IoT and Smart City customers are looking for entire solutions not just software. In order to grow our software revenues, B-Scada will be engaging our customer base as a solution provider, providing not only world class data monitoring solutions but also our expertise and the expertise of our many hardware and software partners. As we move into 2016 we believe that approaching the market with this ecosystem will drive revenue and growth for B-Scada and its partners, as well as provide world class solutions to our valued customers.
Revenue is expected to be generated in 2016 from new directions, from Monitor Sensing Technologies Inc. through sensors sales and the sale of data monitoring services via a SASS model (Software as a Service) using our VoT Platform. Revenue is expected to increase from our IoT product offerings with our VoT Platform and from B-Scada Soluciones Industriales SL., our Spanish subsidiary. Our traditional SCADA and HMI software systems continue to be more and more recognized in the market.
B-Scada has a verbal commitment for additional equity funding to provide inventory and marketing efforts to launch Monitor Sensing Technologies Inc. This effort, together with our SCADA, HMI and IoT solutions will provide revenue for the company from multiple streams and verticals increasing our potential for growth and success.
2015 Results
B-Scada faced some fierce headwinds in 2015, the price of oil and pressures on coal resulted in the loss of significant revenue from the petrochemical and mining industries which accounted for almost half of our revenue. These losses affected our software revenue, consulting and technology licensing. Despite the drop in revenue from the petrochemical sector, Q3 2015 generated the most software revenue of any previous quarter for the company, partially due to new revenue from our Internet of Things (IoT) Platform.
We do not anticipate revenue from petrochemical to return in the near future. We do see revenue growth for software in IoT, Smart Cities and all other verticals and are confident the void will be filled in time. B-Scada has implemented cost reduction measures to bring our expenses in line with our new revenue reality and will be striving to return to profitability as soon as possible.
Revenue for the year ended October 31, 2015 was flat primarily due to the drop in revenue from the petrochemical sector. Revenue for the year was $1,933,321 - down 5% from fiscal 2014. Net loss was $406,534 due primarily to one time expenditures associated with the opening of the Spanish office, incorporation, and research and development costs for Monitoring Sensing Technologies Inc., launching of our VoT Platform initiative and development of CMMS capabilities into our systems. Results are unaudited, preliminary and subject to change.
I think this angle of marketing will certainly appeal to many. I've been following the Swedish snus market and the extreme nicotine choices are increasingly popular. Kind of like the Red Bull vs Coke of tobacco. And if Red Sun is the only one offering higher nicotine, they will stand out. I also like the "little company vs Big Tobacco" angle.
I'm sure Henry will have to fend off some critics with regard to offering a high nicotine cigarette to the marketplace, especially since the company's mission is to reduce harm. However, if these higher nicotine cigs are - in fact- lower in tar than the leading choices, then Red Sun is still a better alternative.
22nd Century’s RED SUN Brand Launches Extremely Nicotine Campaign; Company Showcases ‘Extremist’ RED SUN Brand Enthusia...
Today : Monday 21 December 2015
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company focused on tobacco, announced today that the Company will now highlight the “soul” of its RED SUN brand as “Extremely Nicotine” on consumer advertising materials. This change is in response to strong customer feedback showing that smokers in targeted demographic groups view RED SUN’s high nicotine content as a compelling product feature.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151221005946/en/
RED SUN Extremists display their passion for the novel, high nicotine brand. (Photo: Business Wire)
RED SUN Extremists display their passion for the novel, high nicotine brand. (Photo: Business Wire)
Unlike 22nd Century’s MAGIC brand cigarettes that feature the world’s lowest nicotine tobacco cigarettes (95% less nicotine than conventional brands), independent lab tests show that RED SUN’s high-grade, whole-leaf tobacco contains substantially more nicotine than market-leading brands like Marlboro®, Camel® and Newport®. Made specifically for adult smokers who appreciate a bold, natural tobacco taste, RED SUN cigarettes are produced in 22nd Century’s Mocksville, North Carolina factory. Like “craft brews” that have become popular across the United States, RED SUN caters to discerning smokers who shun mass market cigarettes in favor of small, independent brands that stand for something more.
Though very new to the market and only available in select retail outlets, RED SUN is already appreciated by many smokers as “America’s best cigarette.” 22nd Century describes the brand as “Unapologetic... Authentic... Different.” Positioning RED SUN as a counter-culture brand that offers free-thinking smokers a choice, the Company has been pleasantly surprised at smoker’s enthusiasm for “extreme nicotine.”
To demonstrate their enthusiasm for the RED SUN cigarette brand, dozens of adult smokers – RED SUN Extremists – have entered the Company’s novel RED SUN Permanent Tattoo Promotion. The contest invites adult smokers in select markets across the country to design and wear original RED SUN permanent tattoos on their bodies. Initially expecting only a token number of entries in a handful of cities to participate, the Company is delighted that more than 50 RED SUN customers have already taken up the challenge to become RED SUN emissaries with some of the most fantastic tattoos imaginable. (See RED SUN Extremists in the photos that accompany this article.)
“We own the formula for America’s best, most authentic cigarettes. Indeed, no other brand matches RED SUN’s extreme nicotine,” explained Henry Sicignano III, President and Chief Executive Officer at 22nd Century Group. “RED SUN is bold and decidedly unapologetic… RED SUN gives smokers the freedom to enjoy greater satisfaction with every cigarette.”
Though not every RED SUN smoker has commissioned a permanent tattoo, after launching the RED SUN brand less than one year ago, 22nd Century has found that RED SUN smokers are surprisingly passionate about the brand. Here are a few of the many customer testimonials we have received:
“I tried some RED SUN cigs recently… and thought they were great… the RED SUN cigs were as flavorful if not even bolder than American Spirit. I’ll be buying [RED SUN] again and sharing them with friends. Well done!” – Erick from Oregon
“I love smoking, always have and always will. I find your unapologetic approach refreshing.” – Michael from Minnesota.
“I LOVE RED SUN. They are amazing!” – Megan from New York
“The clerk from the corner store… turned me on to RED SUN; now I wouldn’t smoke anything else!” – David from California
“I admire your company and mission.” – Jack, from New York
About 22nd Century Group, Inc.
22nd Century Group is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company. Visit www.xxiicentury.com for more information.
This is from a year ago but is signals the shift that is starting to occur, not only on a state-by-state level, but also on a Federal level:
"Congress quietly ends federal government's ban on medical marijuana
Tucked deep inside the 1,603-page federal spending measure is a provision that effectively ends the federal government's prohibition on medical marijuana and signals a major shift in drug policy.
The bill's passage over the weekend marks the first time Congress has approved nationally significant legislation backed by legalization advocates. It brings almost to a close two decades of tension between the states and Washington over medical use of marijuana.
Under the provision, states where medical pot is legal would no longer need to worry about federal drug agents raiding retail operations. Agents would be prohibited from doing so."
http://www.latimes.com/nation/la-na-medical-pot-20141216-story.html